Category - New Drugs
FDA Approves Xembify (immune globulin subcutaneous) for Primary Immunodeficiencies
FDA Approves Xpovio (selinexor) for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma
FDA Approves Thiola EC (tiopronin) for the Treatment of Cystinuria
FDA Approves Zirabev (bevacizumab-bvzr), a Biosimilar to Avastin
Dova Pharmaceuticals Announces FDA Approval of Doptelet (avatrombopag) for Treatment of Chronic Immune Thrombocytopenia (ITP)
Alexion Receives FDA Approval of Soliris (eculizumab) for the Treatment of Adults with Neuromyelitis Optica Spectrum Disorder
Janssen Announces FDA Approval of Darzalex (daratumumab) in Combination with Lenalidomide and Dexamethasone for Newly Diagnosed Patients with Multiple Myeloma Who Are Transplant Ineligible
FDA Approves Dupixent (dupilumab) for Chronic Rhinosinusitis with Nasal Polyposis